Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness

Antioxidants and Redox Signaling

Volumn 14, Issue 12, 2011, Pages 2361-2371

  Giannoni, Elisa ^a   Bianchini, Francesca ^a   Calorini, Lido ^a,b   Chiarugi, Paola ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER STEM CELL; CELL CLONE; CYTOKINE RELEASE; DRUG TARGETING; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; METASTASIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; METALLOPROTEASES; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES;

EID: 79957532451     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3727     Document Type: Article

References (48)

1. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, and Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32, 2004. (Pubitemid 38903159)
2. Begley LA, Kasina S, MacDonald J, and Macoska JA. The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine 43: 194-199, 2008.
3. Bhowmick NA, Neilson EG, and Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004. (Pubitemid 39551661)
4. Bissell MJ and Radisky D. Putting tumours in context. Nat Rev Cancer 1: 46-54, 2001. (Pubitemid 33741880)
5. Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH, and Melillo G. Hypoxic induction of an HIF-1alphadependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107: 2705-2712, 2006.
6. Cannito S, Novo E, Compagnone A, Valfre di BL, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, Cravanzola C, Bravoco V, Colombatto S, and Parola M. Redox mechanisms switch on hypoxia-dependent epithelialmesenchymal transition in cancer cells. Carcinogenesis 29: 2267-2278, 2008.
7. Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkotter O, Sies H, and Brenneisen P. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 119: 2727-2738, 2006. (Pubitemid 44184009)
8. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T, and Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161: 933-944, 2003. (Pubitemid 36718426)
9. Christofori G. New signals from the invasive front. Nature 441: 444-450, 2006. (Pubitemid 44050139)
10. Cowin P, Rowlands TM, and Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17: 499-508, 2005. (Pubitemid 41267164)
11. Crawford Y and Ferrara N. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci 30: 624-630, 2009.
12. Desmouliere A, Guyot C, and Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48: 509-517, 2004. (Pubitemid 39360401)
13. Erez N, Truitt M, Olson P, Arron ST, and Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17: 135-147, 2010.
14. Franci C, Takkunen M, Dave N, Alameda F, Gomez S, Rodriguez R, Escriva M, Montserrat-Sentis B, Baro T, Garrido M, Bonilla F, Virtanen I, and Garcia de HA. Expression of Snail protein in tumor-stroma interface. Oncogene 25: 5134-5144, 2006. (Pubitemid 44285982)
15. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 16: 14-23, 2004. (Pubitemid 38368147)
16. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL, and Dang CV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12: 230-238, 2007. (Pubitemid 47333417)
17. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L, and Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelialmesenchymal transition and cancer stemness. Cancer Res 70: 6945-6956, 2010.
18. Giannoni E, Fiaschi T, Ramponi G, and Chiarugi P. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28: 2074-2086, 2009.
19. Gupta S, Srivastava M, Ahmad N, Bostwick DG, and Mukhtar H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 42: 73-78, 2000. (Pubitemid 30004877)
20. Hamanaka RB and Chandel NS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol 21: 894-899, 2009.
21. Kalluri R and Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
22. Khandrika L, Kumar B, Koul S, Maroni P, and Koul HK. Oxidative stress in prostate cancer. Cancer Lett 282: 125-136, 2009.
23. Lee LM, Pan CC, Cheng CJ, Chi CW, and Liu TY. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Anticancer Res 21: 1291-1294, 2001.
24. Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, and Levine AC. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 164: 820-825, 2000. (Pubitemid 30637640)
25. Mantovani A. Role of inflammatory cells and mediators in tumor invasion and metastasis. Cancer Metastasis Rev 29: 241, 2010.
26. Micke P and Ostman A. Tumour-stroma interaction: cancerassociated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45 Suppl 2: S163-S175, 2004. (Pubitemid 39488186)
27. Mori K, Shibanuma M, and Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 64: 7464-7472, 2004. (Pubitemid 39372089)
28. Nelson CM, Khauv D, Bissell MJ, and Radisky DC. Change in cell shape is required for matrix metalloproteinaseinduced epithelial-mesenchymal transition of mammary epithelial cells. J Cell Biochem 105: 25-33, 2008.
29. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166, 2002.
30. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, and Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999. (Pubitemid 29472907)
31. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, and Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
32. Pani G, Galeotti T, and Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29: 351-378, 2010.
33. Parri M and Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 8: 23, 2010.
34. Pathak SK, Sharma RA, Steward WP, Mellon JK, Griffiths TR, and Gescher AJ. Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. Eur J Cancer 41: 61-70, 2005. (Pubitemid 40029659)
35. Pietras K, Pahler J, Bergers G, and Hanahan D. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 5: e19, 2008.
36. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, and Bissell MJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127, 2005. (Pubitemid 40966197)
37. Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, and Matusik RJ. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 63: 2256-2267, 2003. (Pubitemid 36538635)
38. Stasinopoulos I, O'Brien DR, and Bhujwalla ZM. In-flammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2. Cancer Biol Ther 8: 31-35, 2009.
39. Sugimoto H, Mundel TM, Kieran MW, and Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5: 1640-1646, 2006.
40. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
41. Tlsty TD and Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150, 2006.
42. Toullec A, Gerald D, Despouy G, Bourachot B, Cardon M, Lefort S, Richardson M, Rigaill G, Parrini MC, Lucchesi C, Bellanger D, Stern MH, Dubois T, Sastre-Garau X, Delattre O, Vincent-Salomon A, and Mechta-Grigoriou F. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2: 211-230, 2010.
43. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, and Leone G. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: 1084-1091, 2009.
44. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, and Du-Bois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998. (Pubitemid 28257578)
45. Wu K and Bonavida B. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29: 241-254, 2009.
46. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, and Zhou BP. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15: 416-428, 2009.
47. Yang MH and Wu KJ. TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 7: 2090-2096, 2008.
48. Zhang Z and DuBois RN. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20: 4450-4456, 2001. (Pubitemid 32772427)